5.65 USD
+0.33
6.20%
At close Dec 20, 4:00 PM EST
1 day
6.20%
5 days
-12.54%
1 month
87.71%
3 months
-4.40%
6 months
-4.56%
Year to date
-53.76%
1 year
-43.10%
5 years
-94.29%
10 years
-94.29%
 

About: Movano Inc is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. its initial commercial product in development is the Evie Ring, a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.

Employees: 30

0
Funds holding %
of 6,809 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

27% more capital invested

Capital invested by funds: $3.79M [Q2] → $4.79M (+$1.01M) [Q3]

0.52% less ownership

Funds ownership: 14.01% [Q2] → 13.49% (-0.52%) [Q3]

17% less funds holding

Funds holding: 29 [Q2] → 24 (-5) [Q3]

50% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 8

63% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 8

Research analyst outlook

We haven’t received any recent analyst ratings for MOVE.

Financial journalist opinion

Neutral
PRNewsWire
2 weeks ago
Movano Health Receives FDA Clearance for EvieMED Ring
Company's first 510(k) clearance unlocks a TAM of $40 billion in healthcare B2B opportunities PLEASANTON, Calif. , Dec. 2, 2024 /PRNewswire/ -- Movano Health  (Nasdaq: MOVE), a pioneer in health technology, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the pulse oximeter in its EvieMED Ring.
Movano Health Receives FDA Clearance for EvieMED Ring
Neutral
Seeking Alpha
1 month ago
Movano Inc. (MOVE) Q3 2024 Earnings Call Transcript
Movano Inc. (NASDAQ:MOVE ) Q3 2024 Earnings Conference Call November 14, 2024 5:00 PM ET Company Participants J. Cogan - CFO John Mastrototaro - CEO Tyla Bucher - Chief Marketing Officer Michael Soule - Chief Commercial Officer Conference Call Participants Bruce Jackson - The Benchmark Company Operator Ladies and gentlemen, greetings, and welcome to the Movano Health Third Quarter Earnings Conference Call.
Movano Inc. (MOVE) Q3 2024 Earnings Call Transcript
Neutral
PRNewsWire
1 month ago
Movano Health Reports Q3 2024 Financial Results and Provides Business Update
Highlights successful Evie Ring back-in-stock execution Updates status of EvieMED 510(k) application review Focuses on launch of EvieMED and securing B2B opportunities Conference Call at 2:00 PM PT/ 5:00 PM ET Today PLEASANTON, Calif. , Nov. 14, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, reported third quarter 2024 results and provided a business update.
Movano Health Reports Q3 2024 Financial Results and Provides Business Update
Neutral
PRNewsWire
1 month ago
Movano Health Announces Completion of Clinical Study with Cuffless RF Blood Pressure Device
New hardware boasts significant improvements to reduce noise and generate higher fidelity signals PLEASANTON, Calif. , Nov. 7, 2024 /PRNewswire/ -- Movano Health Inc. (Nasdaq: MOVE) announced today that it has tested its newly developed blood pressure wrist wearable as part of its November 5 th and 6th hypoxia clinical trial that took place at the University of California, San Francisco.
Movano Health Announces Completion of Clinical Study with Cuffless RF Blood Pressure Device
Neutral
PRNewsWire
1 month ago
Movano Health to Report Third Quarter 2024 Financial Results on Thursday November 14, 2024
Conference Call at 2:00 PM PT/ 5:00 PM ET PLEASANTON, Calif. , Nov. 6, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced that it will report third quarter 2024 financial and operating results on Thursday November 14, 2024, after the market close.
Movano Health to Report Third Quarter 2024 Financial Results on Thursday November 14, 2024
Neutral
PRNewsWire
1 month ago
Movano Health Provides Update on Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split
Company Continues to Work with Securities Regulators, Legal Advisors and Other Partners to Protect Interests of Shareholders PLEASANTON, Calif. , Nov. 4, 2024 /PRNewswire/ -- Movano Health  (Nasdaq:  MOVE ) (the "Company") provided an update on an investigation to expose apparent manipulation in trading of the Company's common shares, following the recent announcement of a shareholder approved reverse stock split.
Movano Health Provides Update on Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split
Neutral
PRNewsWire
1 month ago
Movano Health Submits Response to FDA as Part of Final Review Phase for EvieMED
Company remains optimistic on the potential for this pioneering healthcare solution PLEASANTON, Calif. , Nov. 4, 2024 /PRNewswire/ -- Movano Health  (NASDAQ:  MOVE ) announced today that it has submitted a complete response package to the FDA as part of the final phase of the Company's 510(k) application review of the EvieMED Ring.
Movano Health Submits Response to FDA as Part of Final Review Phase for EvieMED
Neutral
PRNewsWire
1 month ago
Movano Health Opens Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split
Company Communicating with Securities Regulators, Legal Advisors and Other Partners to Protect Interests of Shareholders PLEASANTON, Calif. , Oct. 31, 2024 /PRNewswire/ --  Movano Health  (Nasdaq:  MOVE ) (the "Company") announced today that it has opened an investigation to expose apparent manipulation in trading of the Company's common shares, following the recent announcement of a shareholder approved reverse stock split.
Movano Health Opens Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split
Neutral
PRNewsWire
1 month ago
Evie Ring Announces Brand Partnership with Lifestyle Content Creator Heidi D'Amelio
Collaboration Will Expand Awareness of Movano's Female First Wearable to D'Amelio's 12 Million Social Media Followers PLEASANTON, Calif. , Oct. 30, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) today announced its first brand partnership with digital creator, wife, mom and entrepreneur Heidi D'Amelio.
Evie Ring Announces Brand Partnership with Lifestyle Content Creator Heidi D'Amelio
Neutral
PRNewsWire
1 month ago
Movano Health Announces Reverse Stock Split
Shares Expected to Begin Trading on Split-Adjusted Basis on October 29, 2024 PLEASANTON, Calif. , Oct. 25, 2024 /PRNewswire/ --  Movano Health  (Nasdaq: MOVE) announced today that it will implement a 1-for-15 reverse stock split of the issued shares of its common stock (the "Reverse Stock Split"), effective at 12:01 a.m.
Movano Health Announces Reverse Stock Split
Charts implemented using Lightweight Charts™